genOway S.A.
ALGEN.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 10% | 17.6% | 21.6% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | -€0 | €0 | -€0 | -€0 |
| % Margin | -8.5% | 93.8% | -7.7% | -26.7% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | €0 | €0 | €0 | -€0 |
| % Margin | 8.2% | 10.3% | 5.6% | -32.8% |
| Other Income/Exp. Net | -€0 | -€0 | -€0 | €0 |
| Pre-Tax Income | -€0 | €0 | €0 | -€0 |
| Tax Expense | -€0 | -€0 | -€0 | -€0 |
| Net Income | €0 | €0 | €0 | -€0 |
| % Margin | 8.3% | 7.8% | 4.6% | -2.3% |
| EPS | 0.19 | 0.17 | 0.088 | -0.037 |
| % Growth | 11.8% | 92.7% | 341% | – |
| EPS Diluted | 0.2 | 0.17 | 0.088 | -0.037 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | €0 | €0 | €0 | -€0 |
| % Margin | 17.7% | 31.7% | 3.1% | -13.4% |